GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Filament Health Corp (NEOE:FH) » Definitions » Valuation Rank

Filament Health (NEOE:FH) Valuation Rank


View and export this data going back to 2021. Start your Free Trial

What is Filament Health Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Filament Health Valuation Rank Related Terms

Thank you for viewing the detailed overview of Filament Health's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Filament Health Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Filament Health Corp (NEOE:FH) » Definitions » Valuation Rank
Comparable Companies
XCNQ:HERB NEOE:TILT TSX:WLLW XCNQ:AYUR XCNQ:BBM XCNQ:CVGR TSXV:DHB XCNQ:RVV XCNQ:BAMM TSXV:MPH ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
FLHLF:USA 7QS:Germany
Address
4475 Wayburne Drive, Unit 210, Burnaby, BC, CAN, V5G 4X4
Website
https://www.filament.health
Filament Health Corp is a natural psychedelic drug development company. Its mission is to see safe, approved, natural psychedelics in the hands of everyone who needs them as soon as possible. The group engages in natural extraction technology commercialization, utilizing its intellectual property portfolio, in-house GMP facility, and Health Canada psilocybin Dealer's License.
Executives
Benjamin Lightburn Director, Senior Officer
Thomas Kineshanko 10% Security Holder
Warren Duncan Senior Officer